Treatment of High-Risk Neuroblastoma

被引：7
|
作者：
Krystal, Julie [1 ]
Foster, Jennifer H. [2 ]
机构：
[1] Cohen Childrens Med Ctr, Zucker Hofstra Sch Med, Dept Pediat, New Hyde Pk, NY 11040 USA
[2] Texas Childrens Canc Ctr, Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA
来源：
CHILDREN-BASEL | 2023年 / 10卷 / 08期
关键词：
neuroblastoma; pediatric oncology; solid tumor; OPEN-LABEL; CLASSIFICATION-SYSTEM; PROGNOSTIC IMPACT; CHILDHOOD-CANCER; FREE SURVIVAL; LOCAL-CONTROL; COG A3973; PHASE-II; CHILDREN; CHEMOTHERAPY;
D O I：
10.3390/children10081302
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
High-risk neuroblastoma is a highly aggressive solid tumor that most commonly presents in early childhood. Advances in treatment through decades of clinical trials and research have led to improved outcomes. This review provides an overview of the current state of treatment for high-risk neuroblastoma.
引用
收藏
页数：11
相关论文
共 50 条
  • [21] Retinoid therapy of high-risk neuroblastoma
    Reynolds, CP
    Matthay, KK
    Villablanca, JG
    Maurer, BJ
    CANCER LETTERS, 2003, 197 (1-2) : 185 - 192
  • [22] Influence of Sarcopenia in High-risk Neuroblastoma
    Kawakubo, Naonori
    Souzaki, Ryota
    Koga, Yuuki
    Kinoshita, Yoshiaki
    Ohga, Shouichi
    Taguchi, Tomoaki
    PEDIATRIC BLOOD & CANCER, 2017, 64 : S43 - S43
  • [23] The transcriptome landscape of high-risk neuroblastoma
    Wei, Jun S.
    Zhang, Shile
    Song, Young K.
    Asgharzadeh, Shahab
    Sindiri, Sivasish
    Wen, Xinyu
    Patidar, Rajesh
    Auvil, Jaime M. Guidry
    Gerhard, Daniela S.
    Seeger, Robert
    Maris, John M.
    Khan, Javed
    CANCER RESEARCH, 2016, 76
  • [24] High-Risk Neuroblastoma: A Surgical Perspective
    Jacobson, Jillian C.
    Clark, Rachael A.
    Chung, Dai H.
    CHILDREN-BASEL, 2023, 10 (02):
  • [25] Mouse models of high-risk neuroblastoma
    Alvin Kamili
    Caroline Atkinson
    Toby N. Trahair
    Jamie I. Fletcher
    Cancer and Metastasis Reviews, 2020, 39 : 261 - 274
  • [26] HIGH-RISK NEUROBLASTOMA: A Therapy in Evolution
    Fong, Abraham
    Park, Julie R.
    PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2009, 26 (08) : 539 - 548
  • [27] Mouse models of high-risk neuroblastoma
    Kamili, Alvin
    Atkinson, Caroline
    Trahair, Toby N.
    Fletcher, Jamie I.
    CANCER AND METASTASIS REVIEWS, 2020, 39 (01) : 261 - 274
  • [28] The genetic landscape of high-risk neuroblastoma
    Trevor J Pugh
    Olena Morozova
    Edward F Attiyeh
    Shahab Asgharzadeh
    Jun S Wei
    Daniel Auclair
    Scott L Carter
    Kristian Cibulskis
    Megan Hanna
    Adam Kiezun
    Jaegil Kim
    Michael S Lawrence
    Lee Lichenstein
    Aaron McKenna
    Chandra Sekhar Pedamallu
    Alex H Ramos
    Erica Shefler
    Andrey Sivachenko
    Carrie Sougnez
    Chip Stewart
    Adrian Ally
    Inanc Birol
    Readman Chiu
    Richard D Corbett
    Martin Hirst
    Shaun D Jackman
    Baljit Kamoh
    Alireza Hadj Khodabakshi
    Martin Krzywinski
    Allan Lo
    Richard A Moore
    Karen L Mungall
    Jenny Qian
    Angela Tam
    Nina Thiessen
    Yongjun Zhao
    Kristina A Cole
    Maura Diamond
    Sharon J Diskin
    Yael P Mosse
    Andrew C Wood
    Lingyun Ji
    Richard Sposto
    Thomas Badgett
    Wendy B London
    Yvonne Moyer
    Julie M Gastier-Foster
    Malcolm A Smith
    Jaime M Guidry Auvil
    Daniela S Gerhard
    Nature Genetics, 2013, 45 : 279 - 284
  • [29] Dinutuximab: A Review in High-Risk Neuroblastoma
    Hoy, Sheridan M.
    TARGETED ONCOLOGY, 2016, 11 (02) : 247 - 253
  • [30] Immunocombination therapy for high-risk neuroblastoma
    Kroesen, Michiel
    Lindau, Dennis
    Hoogerbrugge, Peter
    Adema, Gosse J.
    IMMUNOTHERAPY, 2012, 4 (02) : 163 - 174
12345